Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Paracelsus Medical University, Strubergasse 21, 5020 Salzburg, Austria.
Biocatalysis Group, Technische Universität Berlin, 10623 Berlin, Germany.
Int J Mol Sci. 2023 Sep 13;24(18):14035. doi: 10.3390/ijms241814035.
All known organisms encode 20 canonical amino acids by base triplets in the genetic code. The cellular translational machinery produces proteins consisting mainly of these amino acids. Several hundred natural amino acids serve important functions in metabolism, as scaffold molecules, and in signal transduction. New side chains are generated mainly by post-translational modifications, while others have altered backbones, such as the β- or γ-amino acids, or they undergo stereochemical inversion, e.g., in the case of D-amino acids. In addition, the number of non-canonical amino acids has further increased by chemical syntheses. Since many of these non-canonical amino acids confer resistance to proteolytic degradation, they are potential protease inhibitors and tools for specificity profiling studies in substrate optimization and enzyme inhibition. Other applications include in vitro and in vivo studies of enzyme kinetics, molecular interactions and bioimaging, to name a few. Amino acids with bio-orthogonal labels are particularly attractive, enabling various cross-link and click reactions for structure-functional studies. Here, we cover the latest developments in protease research with non-canonical amino acids, which opens up a great potential, e.g., for novel prodrugs activated by proteases or for other pharmaceutical compounds, some of which have already reached the clinical trial stage.
所有已知的生物体都通过遗传密码中的三联体碱基编码 20 种标准氨基酸。细胞翻译机制产生的蛋白质主要由这些氨基酸组成。几百种天然氨基酸在代谢中具有重要功能,作为支架分子,以及在信号转导中发挥作用。新的侧链主要通过翻译后修饰产生,而其他氨基酸则改变了骨架,例如β-或γ-氨基酸,或者它们经历了立体化学反转,例如 D-氨基酸。此外,通过化学合成进一步增加了非标准氨基酸的数量。由于许多这些非标准氨基酸赋予了对蛋白水解降解的抗性,因此它们是潜在的蛋白酶抑制剂,也是用于底物优化和酶抑制特异性分析研究的工具。其他应用包括酶动力学、分子相互作用和生物成像的体外和体内研究等。具有生物正交标签的氨基酸特别有吸引力,能够进行各种交联和点击反应,用于结构-功能研究。在这里,我们介绍了蛋白酶研究中使用非标准氨基酸的最新进展,这为新型蛋白酶激活前药或其他药物化合物开辟了巨大的潜力,其中一些已经进入临床试验阶段。